Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 41 entries
Sorted by: Best Match Show Resources per page
Polydisperse composition of mixed monolayer-protected, spin-labeled Au nanoparticles.

Analytical chemistry

Wellsted H, Sitsen E, Caragheorgheopol A, Chechik V.
PMID: 15053665
Anal Chem. 2004 Apr 01;76(7):2010-6. doi: 10.1021/ac035465x.

Using EPR spectroscopy and spin-labeled ligands, we have studied product distribution in the ligand exchange reactions of Au nanoparticles. When the incoming ligand was used in excess, the exchanged nanoparticles had uniform composition of the organic shell. Preparative GPC...

Cite
Wellsted H, Sitsen E, Caragheorgheopol A, et al. Polydisperse composition of mixed monolayer-protected, spin-labeled Au nanoparticles. Anal Chem. 2004;76(7):2010-6doi: 10.1021/ac035465x.
Wellsted, H., Sitsen, E., Caragheorgheopol, A., & Chechik, V. (2004). Polydisperse composition of mixed monolayer-protected, spin-labeled Au nanoparticles. Analytical chemistry, 76(7), 2010-6. https://doi.org/10.1021/ac035465x
Wellsted, Helen, et al. "Polydisperse composition of mixed monolayer-protected, spin-labeled Au nanoparticles." Analytical chemistry vol. 76,7 (2004): 2010-6. doi: https://doi.org/10.1021/ac035465x
Wellsted H, Sitsen E, Caragheorgheopol A, Chechik V. Polydisperse composition of mixed monolayer-protected, spin-labeled Au nanoparticles. Anal Chem. 2004 Apr 01;76(7):2010-6. doi: 10.1021/ac035465x. PMID: 15053665.
Copy Download .nbib Format: NLM
Differential expression of viral agents in lymphoma tissues of patients with ABC diffuse large B-cell lymphoma from high and low endemic infectious disease regions.

Oncology letters

Högfeldt T, Jaing C, Loughlin KM, Thissen J, Gardner S, Bahnassy AA, Gharizadeh B, Lundahl J, Österborg A, Porwit A, Zekri AN, Khaled HM, Mellstedt H, Moshfegh A.
PMID: 27698858
Oncol Lett. 2016 Oct;12(4):2782-2788. doi: 10.3892/ol.2016.5012. Epub 2016 Aug 16.

Diffuse large B-cell lymphoma (DLBCL), the most common type of non-Hodgkin's lymphoma (NHL) in adults, accounts for approximately 30-40% of newly diagnosed lymphomas worldwide. Environmental factors, such as viruses and bacteria, may contribute to cancer development through chronic inflammation...

Cite
Högfeldt T, Jaing C, Loughlin KM, et al. Differential expression of viral agents in lymphoma tissues of patients with ABC diffuse large B-cell lymphoma from high and low endemic infectious disease regions. Oncol Lett. 2016;12(4):2782-2788doi: 10.3892/ol.2016.5012.
Högfeldt, T., Jaing, C., Loughlin, K. M., Thissen, J., Gardner, S., Bahnassy, A. A., Gharizadeh, B., Lundahl, J., Österborg, A., Porwit, A., Zekri, A. N., Khaled, H. M., Mellstedt, H., & Moshfegh, A. (2016). Differential expression of viral agents in lymphoma tissues of patients with ABC diffuse large B-cell lymphoma from high and low endemic infectious disease regions. Oncology letters, 12(4), 2782-2788. https://doi.org/10.3892/ol.2016.5012
Högfeldt, Therese, et al. "Differential expression of viral agents in lymphoma tissues of patients with ABC diffuse large B-cell lymphoma from high and low endemic infectious disease regions." Oncology letters vol. 12,4 (2016): 2782-2788. doi: https://doi.org/10.3892/ol.2016.5012
Högfeldt T, Jaing C, Loughlin KM, Thissen J, Gardner S, Bahnassy AA, Gharizadeh B, Lundahl J, Österborg A, Porwit A, Zekri AN, Khaled HM, Mellstedt H, Moshfegh A. Differential expression of viral agents in lymphoma tissues of patients with ABC diffuse large B-cell lymphoma from high and low endemic infectious disease regions. Oncol Lett. 2016 Oct;12(4):2782-2788. doi: 10.3892/ol.2016.5012. Epub 2016 Aug 16. PMID: 27698858; PMCID: PMC5038175.
Copy Download .nbib Format: NLM
Tuneable Time Delay in the Burst Release from Oxidation-Sensitive Polymersomes Made by PISA.

Angewandte Chemie (International ed. in English)

Sobotta FH, Kuchenbrod MT, Gruschwitz FV, Festag G, Bellstedt P, Hoeppener S, Brendel JC.
PMID: 34542227
Angew Chem Int Ed Engl. 2021 Nov 08;60(46):24716-24723. doi: 10.1002/anie.202108928. Epub 2021 Oct 11.

Reactive polymersomes represent a versatile artificial cargo carrier system that can facilitate an immediate release in response to a specific stimulus. The herein presented oxidation-sensitive polymersomes feature a time-delayed release mechanism in an oxidative environment, which can be precisely...

Cite
Sobotta FH, Kuchenbrod MT, Gruschwitz FV, et al. Tuneable Time Delay in the Burst Release from Oxidation-Sensitive Polymersomes Made by PISA. Angew Chem Int Ed Engl. 2021;60(46):24716-24723doi: 10.1002/anie.202108928.
Sobotta, F. H., Kuchenbrod, M. T., Gruschwitz, F. V., Festag, G., Bellstedt, P., Hoeppener, S., & Brendel, J. C. (2021). Tuneable Time Delay in the Burst Release from Oxidation-Sensitive Polymersomes Made by PISA. Angewandte Chemie (International ed. in English), 60(46), 24716-24723. https://doi.org/10.1002/anie.202108928
Sobotta, Fabian H, et al. "Tuneable Time Delay in the Burst Release from Oxidation-Sensitive Polymersomes Made by PISA." Angewandte Chemie (International ed. in English) vol. 60,46 (2021): 24716-24723. doi: https://doi.org/10.1002/anie.202108928
Sobotta FH, Kuchenbrod MT, Gruschwitz FV, Festag G, Bellstedt P, Hoeppener S, Brendel JC. Tuneable Time Delay in the Burst Release from Oxidation-Sensitive Polymersomes Made by PISA. Angew Chem Int Ed Engl. 2021 Nov 08;60(46):24716-24723. doi: 10.1002/anie.202108928. Epub 2021 Oct 11. PMID: 34542227; PMCID: PMC8596869.
Copy Download .nbib Format: NLM
Chlorambucil/Prednisone versus CHOP in Symptomatic Chronic Lymphocytic Leukemias of B-Cell type. A Randomized Trial.

Leukemia & lymphoma

Kimby E, Mellstedt H.
PMID: 27463487
Leuk Lymphoma. 1991;5:93-6. doi: 10.3109/10428199109103386.

The therapeutic efficacy of intensive chemotherapy (CHOP) versus palliative low-dose therapy (chlorambucil/prednisone, ChP) was studied in a randomized trial including 258 previously untreated patients with asymptomatic low-grade non-Hodgkin lymphomas stage III and IV. The patients were stratified according to...

Cite
Kimby E, Mellstedt H. Chlorambucil/Prednisone versus CHOP in Symptomatic Chronic Lymphocytic Leukemias of B-Cell type. A Randomized Trial. Leuk Lymphoma. 1991;5:93-6doi: 10.3109/10428199109103386.
Kimby, E., & Mellstedt, H. (1991). Chlorambucil/Prednisone versus CHOP in Symptomatic Chronic Lymphocytic Leukemias of B-Cell type. A Randomized Trial. Leukemia & lymphoma, 593-6. https://doi.org/10.3109/10428199109103386
Kimby, E, and Mellstedt, H. "Chlorambucil/Prednisone versus CHOP in Symptomatic Chronic Lymphocytic Leukemias of B-Cell type. A Randomized Trial." Leukemia & lymphoma vol. 5 (1991): 93-6. doi: https://doi.org/10.3109/10428199109103386
Kimby E, Mellstedt H. Chlorambucil/Prednisone versus CHOP in Symptomatic Chronic Lymphocytic Leukemias of B-Cell type. A Randomized Trial. Leuk Lymphoma. 1991;5:93-6. doi: 10.3109/10428199109103386. PMID: 27463487.
Copy Download .nbib Format: NLM
Correction: Durable Carcinoembryonic Antigen (CEA)-Specific Humoral and Cellular Immune Responses in Colorectal Carcinoma Patients Vaccinated with Recombinant CEA and Granulocyte/Macrophage Colony-Stimulating Factor.

Clinical cancer research : an official journal of the American Association for Cancer Research

Ullenhag GJ, Frödin JE, Jeddi-Tehrani M, Lidströmer N, Strigård K, Eriksson E, Samanci A, Choudhury A, Nilsson B, Rossmann ED, Mosolits S, Mellstedt H.
PMID: 31043387
Clin Cancer Res. 2019 May 01;25(9):2939. doi: 10.1158/1078-0432.CCR-19-0732.

No abstract available.

Cite
Ullenhag GJ, Frödin JE, Jeddi-Tehrani M, et al. Correction: Durable Carcinoembryonic Antigen (CEA)-Specific Humoral and Cellular Immune Responses in Colorectal Carcinoma Patients Vaccinated with Recombinant CEA and Granulocyte/Macrophage Colony-Stimulating Factor. Clin Cancer Res. 2019;25(9):2939doi: 10.1158/1078-0432.CCR-19-0732.
Ullenhag, G. J., Frödin, J. E., Jeddi-Tehrani, M., Lidströmer, N., Strigård, K., Eriksson, E., Samanci, A., Choudhury, A., Nilsson, B., Rossmann, E. D., Mosolits, S., & Mellstedt, H. (2019). Correction: Durable Carcinoembryonic Antigen (CEA)-Specific Humoral and Cellular Immune Responses in Colorectal Carcinoma Patients Vaccinated with Recombinant CEA and Granulocyte/Macrophage Colony-Stimulating Factor. Clinical cancer research : an official journal of the American Association for Cancer Research, 25(9), 2939. https://doi.org/10.1158/1078-0432.CCR-19-0732
Ullenhag, Gustav J, et al. "Correction: Durable Carcinoembryonic Antigen (CEA)-Specific Humoral and Cellular Immune Responses in Colorectal Carcinoma Patients Vaccinated with Recombinant CEA and Granulocyte/Macrophage Colony-Stimulating Factor." Clinical cancer research : an official journal of the American Association for Cancer Research vol. 25,9 (2019): 2939. doi: https://doi.org/10.1158/1078-0432.CCR-19-0732
Ullenhag GJ, Frödin JE, Jeddi-Tehrani M, Lidströmer N, Strigård K, Eriksson E, Samanci A, Choudhury A, Nilsson B, Rossmann ED, Mosolits S, Mellstedt H. Correction: Durable Carcinoembryonic Antigen (CEA)-Specific Humoral and Cellular Immune Responses in Colorectal Carcinoma Patients Vaccinated with Recombinant CEA and Granulocyte/Macrophage Colony-Stimulating Factor. Clin Cancer Res. 2019 May 01;25(9):2939. doi: 10.1158/1078-0432.CCR-19-0732. PMID: 31043387.
Copy Download .nbib Format: NLM
[Cheaper with biosimilars, but safety comes first].

Lakartidningen

Mellstedt H.
PMID: 24946487
Lakartidningen. 2014 May 27-Jun 10;111(22):1011.

No abstract available.

Cite
Mellstedt H. Billigare med biosimilarer - men säkerheten går först. [Cheaper with biosimilars, but safety comes first]. Lakartidningen. 2014;111(22):1011
Mellstedt, H. (2014). Billigare med biosimilarer - men säkerheten går först. [Cheaper with biosimilars, but safety comes first]. Lakartidningen, 111(22), 1011.
Mellstedt, Håkan. "Billigare med biosimilarer - men säkerheten går först." [Cheaper with biosimilars, but safety comes first]. Lakartidningen vol. 111,22 (2014): 1011.
Mellstedt H. Billigare med biosimilarer - men säkerheten går först. [Cheaper with biosimilars, but safety comes first]. Lakartidningen. 2014 May 27-Jun 10;111(22):1011. Swedish. PMID: 24946487.
Copy Download .nbib Format: NLM
Preorganization in a Cleft-Type Anion Receptor Featuring Iodo-1,2,3-Triazoles As Halogen Bond Donors.

Organic letters

Tepper R, Schulze B, Görls H, Bellstedt P, Jäger M, Schubert US.
PMID: 26588346
Org Lett. 2015 Dec 04;17(23):5740-3. doi: 10.1021/acs.orglett.5b02760. Epub 2015 Nov 20.

Preorganization via intramolecular hydrogen bonds was applied in a cleft-type receptor by exploiting the excellent halogen bond donor ability as well as hydrogen bond acceptor function of iodo-1,2,3-triazoles. As investigated by isothermal calorimetric titrations, the restriction of conformational freedom...

Cite
Tepper R, Schulze B, Görls H, et al. Preorganization in a Cleft-Type Anion Receptor Featuring Iodo-1,2,3-Triazoles As Halogen Bond Donors. Org Lett. 2015;17(23):5740-3doi: 10.1021/acs.orglett.5b02760.
Tepper, R., Schulze, B., Görls, H., Bellstedt, P., Jäger, M., & Schubert, U. S. (2015). Preorganization in a Cleft-Type Anion Receptor Featuring Iodo-1,2,3-Triazoles As Halogen Bond Donors. Organic letters, 17(23), 5740-3. https://doi.org/10.1021/acs.orglett.5b02760
Tepper, Ronny, et al. "Preorganization in a Cleft-Type Anion Receptor Featuring Iodo-1,2,3-Triazoles As Halogen Bond Donors." Organic letters vol. 17,23 (2015): 5740-3. doi: https://doi.org/10.1021/acs.orglett.5b02760
Tepper R, Schulze B, Görls H, Bellstedt P, Jäger M, Schubert US. Preorganization in a Cleft-Type Anion Receptor Featuring Iodo-1,2,3-Triazoles As Halogen Bond Donors. Org Lett. 2015 Dec 04;17(23):5740-3. doi: 10.1021/acs.orglett.5b02760. Epub 2015 Nov 20. PMID: 26588346.
Copy Download .nbib Format: NLM
Sequential acquisition of multi-dimensional heteronuclear chemical shift correlation spectra with ¹H detection.

Scientific reports

Bellstedt P, Ihle Y, Wiedemann C, Kirschstein A, Herbst C, Görlach M, Ramachandran R.
PMID: 24671105
Sci Rep. 2014 Mar 27;4:4490. doi: 10.1038/srep04490.

RF pulse schemes for the simultaneous acquisition of heteronuclear multi-dimensional chemical shift correlation spectra, such as {HA(CA)NH & HA(CACO)NH}, {HA(CA)NH & H(N)CAHA} and {H(N)CAHA & H(CC)NH}, that are commonly employed in the study of moderately-sized protein molecules, have been...

Cite
Bellstedt P, Ihle Y, Wiedemann C, et al. Sequential acquisition of multi-dimensional heteronuclear chemical shift correlation spectra with ¹H detection. Sci Rep. 2014;4:4490doi: 10.1038/srep04490.
Bellstedt, P., Ihle, Y., Wiedemann, C., Kirschstein, A., Herbst, C., Görlach, M., & Ramachandran, R. (2014). Sequential acquisition of multi-dimensional heteronuclear chemical shift correlation spectra with ¹H detection. Scientific reports, 44490. https://doi.org/10.1038/srep04490
Bellstedt, Peter, et al. "Sequential acquisition of multi-dimensional heteronuclear chemical shift correlation spectra with ¹H detection." Scientific reports vol. 4 (2014): 4490. doi: https://doi.org/10.1038/srep04490
Bellstedt P, Ihle Y, Wiedemann C, Kirschstein A, Herbst C, Görlach M, Ramachandran R. Sequential acquisition of multi-dimensional heteronuclear chemical shift correlation spectra with ¹H detection. Sci Rep. 2014 Mar 27;4:4490. doi: 10.1038/srep04490. PMID: 24671105; PMCID: PMC3967198.
Copy Download .nbib Format: NLM
Scope and Limitations of the s-Block Metal-Mediated Pudovik Reaction.

Chemistry (Weinheim an der Bergstrasse, Germany)

Fener BE, Schüler P, Ueberschaar N, Bellstedt P, Görls H, Krieck S, Westerhausen M.
PMID: 32027050
Chemistry. 2020 Jun 05;26(32):7235-7243. doi: 10.1002/chem.201905565. Epub 2020 May 11.

The hydrophosphorylation of phenylacetylene with di(aryl)phosphane oxides Ar

Cite
Fener BE, Schüler P, Ueberschaar N, et al. Scope and Limitations of the s-Block Metal-Mediated Pudovik Reaction. Chemistry. 2020;26(32):7235-7243doi: 10.1002/chem.201905565.
Fener, B. E., Schüler, P., Ueberschaar, N., Bellstedt, P., Görls, H., Krieck, S., & Westerhausen, M. (2020). Scope and Limitations of the s-Block Metal-Mediated Pudovik Reaction. Chemistry (Weinheim an der Bergstrasse, Germany), 26(32), 7235-7243. https://doi.org/10.1002/chem.201905565
Fener, Benjamin E, et al. "Scope and Limitations of the s-Block Metal-Mediated Pudovik Reaction." Chemistry (Weinheim an der Bergstrasse, Germany) vol. 26,32 (2020): 7235-7243. doi: https://doi.org/10.1002/chem.201905565
Fener BE, Schüler P, Ueberschaar N, Bellstedt P, Görls H, Krieck S, Westerhausen M. Scope and Limitations of the s-Block Metal-Mediated Pudovik Reaction. Chemistry. 2020 Jun 05;26(32):7235-7243. doi: 10.1002/chem.201905565. Epub 2020 May 11. PMID: 32027050; PMCID: PMC7317549.
Copy Download .nbib Format: NLM
Virus reactivations and serology patterns following first-line therapy with alemtuzumab or fludarabine-based combination therapy in patients with chronic lymphocytic leukemia.

Blood cancer journal

Karlsson C, Dahl H, Lundin J, Rossmann E, Brytting M, Mellstedt H, Linde A, Osterborg A.
PMID: 22829166
Blood Cancer J. 2011 Jun;1(6):e22. doi: 10.1038/bcj.2011.20. Epub 2011 Jun 10.

No abstract available.

Cite
Karlsson C, Dahl H, Lundin J, et al. Virus reactivations and serology patterns following first-line therapy with alemtuzumab or fludarabine-based combination therapy in patients with chronic lymphocytic leukemia. Blood Cancer J. 2011;1(6):e22doi: 10.1038/bcj.2011.20.
Karlsson, C., Dahl, H., Lundin, J., Rossmann, E., Brytting, M., Mellstedt, H., Linde, A., & Osterborg, A. (2011). Virus reactivations and serology patterns following first-line therapy with alemtuzumab or fludarabine-based combination therapy in patients with chronic lymphocytic leukemia. Blood cancer journal, 1(6), e22. https://doi.org/10.1038/bcj.2011.20
Karlsson, C, et al. "Virus reactivations and serology patterns following first-line therapy with alemtuzumab or fludarabine-based combination therapy in patients with chronic lymphocytic leukemia." Blood cancer journal vol. 1,6 (2011): e22. doi: https://doi.org/10.1038/bcj.2011.20
Karlsson C, Dahl H, Lundin J, Rossmann E, Brytting M, Mellstedt H, Linde A, Osterborg A. Virus reactivations and serology patterns following first-line therapy with alemtuzumab or fludarabine-based combination therapy in patients with chronic lymphocytic leukemia. Blood Cancer J. 2011 Jun;1(6):e22. doi: 10.1038/bcj.2011.20. Epub 2011 Jun 10. PMID: 22829166; PMCID: PMC3255266.
Copy Download .nbib Format: NLM
A Randomized Comparison of Doxorubicin and Doxorubicin-DNA in the Treatment of Acute NonLymphoblastic Leukemia.

Leukemia & lymphoma

Paul C, Tidefelt U, Gahrton G, Björkholm M, Järnmark M, Killander A, Kimby E, Liliemark J, Lindeberg A, Lindquist R, Lockner D, Lönnqvist B, Mellstedt H, Merk K, Palmblad J, Peterson C, Simonsson B, Stalfelt AM, Sundström C, Wadman B, Wedelin C, Udén AM, Öberg G, Öst Å.
PMID: 27467426
Leuk Lymphoma. 1991;3(5):355-64. doi: 10.3109/10428199109070279.

In the light of previous findings that treatment of leukemia patients with DNA-linked doxorubicin gave higher doxorubicin concentrations in leukemic cells than treatment with doxorubicin alone, the Leukemia Group of Middle Sweden performed a randomized clinical trial to compare...

Cite
Paul C, Tidefelt U, Gahrton G, et al. A Randomized Comparison of Doxorubicin and Doxorubicin-DNA in the Treatment of Acute NonLymphoblastic Leukemia. Leuk Lymphoma. 1991;3(5):355-64doi: 10.3109/10428199109070279.
Paul, C., Tidefelt, U., Gahrton, G., Björkholm, M., Järnmark, M., Killander, A., Kimby, E., Liliemark, J., Lindeberg, A., Lindquist, R., Lockner, D., Lönnqvist, B., Mellstedt, H., Merk, K., Palmblad, J., Peterson, C., Simonsson, B., Stalfelt, A. M., Sundström, C., Wadman, B., Wedelin, C., Udén, A. M., Öberg, G., & Öst, �. �. (1991). A Randomized Comparison of Doxorubicin and Doxorubicin-DNA in the Treatment of Acute NonLymphoblastic Leukemia. Leukemia & lymphoma, 3(5), 355-64. https://doi.org/10.3109/10428199109070279
Paul, C, et al. "A Randomized Comparison of Doxorubicin and Doxorubicin-DNA in the Treatment of Acute NonLymphoblastic Leukemia." Leukemia & lymphoma vol. 3,5 (1991): 355-64. doi: https://doi.org/10.3109/10428199109070279
Paul C, Tidefelt U, Gahrton G, Björkholm M, Järnmark M, Killander A, Kimby E, Liliemark J, Lindeberg A, Lindquist R, Lockner D, Lönnqvist B, Mellstedt H, Merk K, Palmblad J, Peterson C, Simonsson B, Stalfelt AM, Sundström C, Wadman B, Wedelin C, Udén AM, Öberg G, Öst Å. A Randomized Comparison of Doxorubicin and Doxorubicin-DNA in the Treatment of Acute NonLymphoblastic Leukemia. Leuk Lymphoma. 1991;3(5):355-64. doi: 10.3109/10428199109070279. PMID: 27467426.
Copy Download .nbib Format: NLM
Acetylene, Not Ethylene, Inactivates the Uptake Hydrogenase of Actinorhizal Nodules during Acetylene Reduction Assays.

Plant physiology

Sellstedt A, Winship LJ.
PMID: 16667724
Plant Physiol. 1990 Sep;94(1):91-4. doi: 10.1104/pp.94.1.91.

Acetylene reduction assays were shown to inactivate uptake hydrogenase activity to different extents in one Casuarina and two Alnus symbioses. Inactivation was found to be caused by C(2)H(2) and not by C(2)H(4). Acetylene completely inactivated the hydrogenase activity of...

Cite
Sellstedt A, Winship LJ. Acetylene, Not Ethylene, Inactivates the Uptake Hydrogenase of Actinorhizal Nodules during Acetylene Reduction Assays. Plant Physiol. 1990;94(1):91-4doi: 10.1104/pp.94.1.91.
Sellstedt, A., & Winship, L. J. (1990). Acetylene, Not Ethylene, Inactivates the Uptake Hydrogenase of Actinorhizal Nodules during Acetylene Reduction Assays. Plant physiology, 94(1), 91-4. https://doi.org/10.1104/pp.94.1.91
Sellstedt, A, and Winship, L J. "Acetylene, Not Ethylene, Inactivates the Uptake Hydrogenase of Actinorhizal Nodules during Acetylene Reduction Assays." Plant physiology vol. 94,1 (1990): 91-4. doi: https://doi.org/10.1104/pp.94.1.91
Sellstedt A, Winship LJ. Acetylene, Not Ethylene, Inactivates the Uptake Hydrogenase of Actinorhizal Nodules during Acetylene Reduction Assays. Plant Physiol. 1990 Sep;94(1):91-4. doi: 10.1104/pp.94.1.91. PMID: 16667724; PMCID: PMC1077194.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 41 entries